ppps norm-setting and policy challenges

Public health, innovation and intellectual property1 |

PPPs Norm-setting and Policy Challenges

What role for PDPs in a future framework for neglected disease

research?

ICTSD, Geneva, June 2013

Dr Peter Beyer

PPPs Norm-setting and Policy Challenges

What role for PDPs in a future framework for neglected disease

research?

ICTSD, Geneva, June 2013

Dr Peter Beyer


World Health Assembly 2013World Health Assembly 2013

WHA66.22 inter alia

REQUESTS the Director-General

(6) to explore and evaluate existing mechanisms for contributions to health R&D and, if there is no suitable mechanism, to develop a proposal for effective mechanisms, including pooling resources and voluntary contributions, as well as a plan to monitor their effectiveness independently

(8) to report on […] the evaluation of existing mechanisms for contributions to health R&D […] to the 67th World Health Assembly, through the Executive Board at its 134th session; […]


What are we trying to achieve?What are we trying to achieve?


DRAFT WORKING PAPER 3FINANCING MECHANISMS FOR HEALTH R&D

DRAFT WORKING PAPER 3FINANCING MECHANISMS FOR HEALTH R&D

Draft working paper

Explores option of adapting an existing instrument to increase funding of R&D for diseases disproportionately affecting developing countries (pooling funding)

identifies a number of mechanisms that could be suitable starting points and

presents criteria that could be used to assess suitability of a range of existing mechanisms.


Existing mechanisms in the area of healthExisting mechanisms in the area of health

ANDI

DNDi

EMBL

GAVI Alliance

Global Fund

IARC

IVI

MMV

PATH

RBM

WHO/TDR

UNITAID


Assessment criteria Assessment criteria

Adaptability: can the mechanism easily be adapted to take up the global funding of health R&D

Scope of research: Which disease areas and technologies are covered?

Geographical scope: if and to what extent the mechanism is geographically limited

Governance: is the governing structure inclusive?

Experience in funding R&D

Experience in managing R&D

Transparency: are the criteria used to distribute funding and the minutes of

governing body meetings publicly available?


Where are we heading?Where are we heading?

Ideally in the end (if Member States so agree):– Research gaps will be identified by the health R&D observatory– Based on this data research priorities will be identified in

conjunction with a new voluntary funding mechanism– New voluntary funding mechanism

Impact on IP management (by PDPs)?

Funding will be linked with certain requirements/principles for accessibility and availability, including IP management


ContactContact

Dr Peter BeyerSenior Advisor, WHO

Department of Public Health, Innovation and Intellectual Property

http://www.who.int/phi/en/[email protected]

.

ppps norm-setting and policy challenges

Documents